Literature DB >> 34341496

Developing breakthrough psychiatric treatments by modulating G protein-coupled receptors on prefrontal cortex somatostatin interneurons.

Nicole A Crowley1, Max E Joffe2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34341496      PMCID： PMC8617253          DOI： 10.1038/s41386-021-01119-x

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  4 in total

Review 1.  Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments.

Authors:  Ronald S Duman; Gerard Sanacora; John H Krystal
Journal:  Neuron       Date:  2019-04-03       Impact factor: 17.173

Review 2.  Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders.

Authors:  Thomas Prévot; Etienne Sibille
Journal:  Mol Psychiatry       Date:  2020-04-28       Impact factor: 15.992

3.  Prefrontal somatostatin interneurons encode fear memory.

Authors:  Kirstie A Cummings; Roger L Clem
Journal:  Nat Neurosci       Date:  2019-12-16       Impact factor: 24.884

4.  Forced Abstinence From Alcohol Induces Sex-Specific Depression-Like Behavioral and Neural Adaptations in Somatostatin Neurons in Cortical and Amygdalar Regions.

Authors:  Nigel C Dao; Malini Suresh Nair; Sarah N Magee; J Brody Moyer; Veronica Sendao; Dakota F Brockway; Nicole A Crowley
Journal:  Front Behav Neurosci       Date:  2020-05-27       Impact factor: 3.558
  4 in total
  3 in total

1.  Adolescent Alcohol and Stress Exposure Rewires Key Cortical Neurocircuitry.

Authors:  Avery R Sicher; Arielle Duerr; William D Starnes; Nicole A Crowley
Journal:  Front Neurosci       Date:  2022-05-17       Impact factor: 5.152

Review 2.  Targeting prefrontal cortex GABAergic microcircuits for the treatment of alcohol use disorder.

Authors:  Kenneth N Fish; Max E Joffe
Journal:  Front Synaptic Neurosci       Date:  2022-08-29

Review 3.  Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.

Authors:  Deborah J Luessen; P Jeffrey Conn
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.